DZ743A1 - Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation. - Google Patents

Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.

Info

Publication number
DZ743A1
DZ743A1 DZ850024A DZ850024A DZ743A1 DZ 743 A1 DZ743 A1 DZ 743A1 DZ 850024 A DZ850024 A DZ 850024A DZ 850024 A DZ850024 A DZ 850024A DZ 743 A1 DZ743 A1 DZ 743A1
Authority
DZ
Algeria
Prior art keywords
well
preparation process
pyridine derivatives
derivatives substituted
furo
Prior art date
Application number
DZ850024A
Other languages
English (en)
French (fr)
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DZ743A1 publication Critical patent/DZ743A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DZ850024A 1984-02-02 1985-01-26 Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation. DZ743A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives

Publications (1)

Publication Number Publication Date
DZ743A1 true DZ743A1 (fr) 2004-09-13

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ850024A DZ743A1 (fr) 1984-02-02 1985-01-26 Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.

Country Status (24)

Country Link
US (1) US4581362A (en, 2012)
JP (1) JPS60181088A (en, 2012)
AT (1) AT391700B (en, 2012)
BE (1) BE901545A (en, 2012)
CA (1) CA1300148C (en, 2012)
CH (1) CH663023A5 (en, 2012)
DE (1) DE3503435A1 (en, 2012)
DK (1) DK158951C (en, 2012)
DZ (1) DZ743A1 (en, 2012)
ES (1) ES8607308A1 (en, 2012)
FI (1) FI82051C (en, 2012)
FR (2) FR2559062B1 (en, 2012)
GB (1) GB8402740D0 (en, 2012)
HK (1) HK92587A (en, 2012)
IE (1) IE58229B1 (en, 2012)
IT (1) IT1200587B (en, 2012)
LU (1) LU85744A1 (en, 2012)
MA (1) MA20342A1 (en, 2012)
NL (1) NL8500241A (en, 2012)
NO (1) NO160369C (en, 2012)
OA (1) OA07947A (en, 2012)
PT (1) PT79913B (en, 2012)
SE (2) SE460903B (en, 2012)
ZA (1) ZA85508B (en, 2012)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
SI3141542T1 (sl) 2011-12-28 2020-11-30 Global Blood Therapeutics, Inc. Substituirane spojine benzaldehida in metode njihove uporabe pri povečanju oksigenacije tkiva
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
ES2852054T3 (es) 2013-03-15 2021-09-10 Global Blood Therapeutics Inc Compuestos y usos de los mismos para la modulación de hemoglobina
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP2970308B1 (en) 2013-03-15 2021-07-14 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AP2015008718A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
CN105431147A (zh) 2014-02-07 2016-03-23 全球血液疗法股份有限公司 2-羟基-6-((2-(1-异丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)苯甲醛的游离碱的结晶多晶型物
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
WO2017096230A1 (en) 2015-12-04 2017-06-08 Global Blood Therapeutics, Inc. Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
ES2966707T3 (es) 2018-10-01 2024-04-23 Global Blood Therapeutics Inc Moduladores de la hemoglobina para el tratamiento de la drepanocitosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (en, 2012) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
FR2559152A1 (fr) 1985-08-09
JPS60181088A (ja) 1985-09-14
BE901545A (fr) 1985-07-22
IE850241L (en) 1985-08-02
DK45585D0 (da) 1985-02-01
FR2559062B1 (fr) 1987-05-22
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
LU85744A1 (fr) 1985-07-24
FI850275A0 (fi) 1985-01-22
ATA27585A (de) 1990-05-15
DK158951C (da) 1990-12-31
DK45585A (da) 1985-08-03
ZA85508B (en) 1985-11-27
CA1300148C (en) 1992-05-05
IT8519327A0 (it) 1985-02-01
DE3503435C2 (en, 2012) 1991-11-07
NO160369B (no) 1989-01-02
OA07947A (fr) 1987-01-31
PT79913B (en) 1986-11-10
FI82051C (fi) 1991-01-10
GB8402740D0 (en) 1984-03-07
IE58229B1 (en) 1993-08-11
SE8500460L (sv) 1985-08-03
IT1200587B (it) 1989-01-27
CH663023A5 (fr) 1987-11-13
MA20342A1 (fr) 1985-10-01
FR2559152B1 (fr) 1987-05-22
PT79913A (en) 1985-03-01
SE8500460D0 (sv) 1985-02-01
AT391700B (de) 1990-11-12
US4581362A (en) 1986-04-08
ES540080A0 (es) 1986-05-16
JPH0240069B2 (en, 2012) 1990-09-10
NL8500241A (nl) 1985-09-02
SE460903B (sv) 1989-12-04
FR2559062A1 (fr) 1985-08-09
HK92587A (en) 1987-12-11
FI82051B (fi) 1990-09-28
DK158951B (da) 1990-08-06
NO850399L (no) 1985-08-05
DE3503435A1 (de) 1985-08-08
NO160369C (no) 1989-04-12

Similar Documents

Publication Publication Date Title
DZ743A1 (fr) Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.
DZ376A1 (fr) Nouveaux dérivés de la furo (3,4-c)-pyridine et leur préparation.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
MA19716A1 (fr) Procede de preparation de nouveaux derives 3- ceto a 4,9 19- norsteroides .
RO91871A (ro) Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
OA07699A (fr) Dérivés de la furo-(3,4-c)-pyridine leur préparation et compositions thérapeutiques contenant ces dérivés.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA05575A (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
OA05403A (fr) Nouveaux dérivés de la thiazolo [3,4-b] isoquinoléine et leur procédé de préparation.
DZ1499A1 (fr) Méthode de préparation de dérivés de furo (3,4-c)pyridine sous forme non-racémique.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
DZ850A1 (fr) Nouveaux dérivés de la phénéthylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procédé de préparation.
OA08088A (fr) Nouveau procédé de préparation des dérivés de la furo-(3,4-C)-pyridine substitués en position 6.
DZ851A1 (fr) Nouveaux dérivés de la pyridine et leur procédé depréparation.
DZ773A1 (fr) Nouveaux dérivés du pyrane ainsi que leur procédé de préparation.
ES546136A0 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato.
DZ779A1 (fr) Nouveaux dérivés de la quinoléine ainse que leur procédé de préparation.
FI850994A7 (fi) Menetelmä uusien 1,2,4 -triatsasykloalkadieenijohdannaisten valmistamiseksi.
OA08076A (fr) Acide dihdro-5,6-4H-cyclopenta[b] thiophènecarboxyliques-6, procédés de préparation.
OA05555A (fr) Dérivés de 1,3-dihydro-l'-diméthylphoephinylalkyl-3-phénylspiro [isobenzofuranne-cycloazalcanes], leur procédé de préparation et leur application.
BE881764A (fr) NOUVEAUX DERIVES DE LA PYRIDO (3,4-e) -ASTRIAZINE ET PROCEDE DE PREPARATION DE CES DERIVES
MA21352A1 (fr) Procede de preparation de nouveaux derives de thieno-imidazole substitues.